Otros idiomas EyeGene Inc.

Acciones

A185490

KR7185490000

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 22/05/2024			Varia. Cinco días.	Varia. 1 de enero.
3.150 ^KRW	+1,78 %		+5,18 %	-26,14 %

2023	EyeGene Inc. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2023	CI
2023	EyeGene Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2022	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

EyeGene Inc. announced that it has received KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.	21/12
EyeGene Inc. announced that it expects to receive KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.	13/12
EyeGene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
EyeGene Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	15/03/23
EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index	07/04/22
Maravai LifeSciences : Says Unit TriLink To Supply Proprietary Technology to EyeGene for Production of COVID-19 Vaccine	04/10/21
EyeGene Inc.(KOSDAQ:A185490) added to S&P Global BMI Index	20/09/21
EyeGene Inc. announced that it has received KRW 22 billion in funding from a group of investors	18/09/20
EyeGene Inc. announced that it expects to receive KRW 22 billion in funding from a group of investors	16/09/20
EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index	23/09/19
EyeGene Inc. announced that it has received KRW 29.9998664 billion in funding from Meritz Securities Co., Ltd., Investment Arm, IBK Capital Corporation, Korea Investment & Securities Co., Ltd., Investment Arm	28/09/18
EyeGene Inc. announced that it expects to receive KRW 29.9998664 billion in funding from a group of investors	20/09/18
EyeGene Inc. announced that it has received KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.	15/12/17
EyeGene Inc. announced that it has received KRW 12.6 billion in funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc.	14/12/17
EyeGene Inc. announced that it expects to receive funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc. and other investors	12/12/17
EyeGene Inc. announced that it expects to receive KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.	12/12/17
EyeGene, Inc.(XKON:A185490) added to S&P Global BMI Index	21/03/16
EyeGene, Inc. completed the sale of ICM co., Ltd.	30/12/15
EyeGene, Inc. agreed to sell ICM co., Ltd for KRW 90 million.	29/12/15
LB Investment Inc. through its fund LB Gemini New Growth Fund 16 acquired an unknown stake in EyeGene, Inc. from KoFC-Hanwha Pioneer Champ 2010 Fund 14 and 09-4 Hanwha Venture Investment Partnership, funds of Hanwha Investment Corp for KRW 1.7 billion.	04/11/14

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas EyeGene Inc.

Acciones

A185490

KR7185490000

Otros idiomas

Filtros